Abstract
Biomacromolecular information is hinged by sequence and structure representations. Because structure is often more conserved than sequence, achieving function inference from structural similarity is easier than from sequence analysis. However, structural information is sparse and only available for a small part of the protein space. Detecting subtle similarities between proteins from sequence depends strongly on the representations used. Continuous-space representations yield promising results in comparative evolution analysis, structural classification and sequence-function/property relationship studies. These simple methods provide a pre-classification and/or feature generation stages to sophisticated classification methods. We review the state-of-the-art in protein sequence graphical representations along with some derived metrics for statistical pattern recognition analysis. In addition, the binding stability pattern of protease-inhibitor complexes is modelled from H-depleted molecular graph representation of protease sequences and ligands using support vector machines with about 80% prediction accuracy.
Keywords: Chaos game representation, protein graph, QSAR analysis, pseudo-folding representation.
Current Bioinformatics
Title: Graphical Representations of Protein Sequences for Alignment-Free Comparative and Predictive Studies. Recognition of Protease Inhibition Pattern from H-Depleted Molecular Graph Representation of Protease Sequences
Volume: 5 Issue: 4
Author(s): Michael Fernandez, Julio Caballero, Leyden Fernandez and Akinori Sarai
Affiliation:
Keywords: Chaos game representation, protein graph, QSAR analysis, pseudo-folding representation.
Abstract: Biomacromolecular information is hinged by sequence and structure representations. Because structure is often more conserved than sequence, achieving function inference from structural similarity is easier than from sequence analysis. However, structural information is sparse and only available for a small part of the protein space. Detecting subtle similarities between proteins from sequence depends strongly on the representations used. Continuous-space representations yield promising results in comparative evolution analysis, structural classification and sequence-function/property relationship studies. These simple methods provide a pre-classification and/or feature generation stages to sophisticated classification methods. We review the state-of-the-art in protein sequence graphical representations along with some derived metrics for statistical pattern recognition analysis. In addition, the binding stability pattern of protease-inhibitor complexes is modelled from H-depleted molecular graph representation of protease sequences and ligands using support vector machines with about 80% prediction accuracy.
Export Options
About this article
Cite this article as:
Fernandez Michael, Caballero Julio, Fernandez Leyden and Sarai Akinori, Graphical Representations of Protein Sequences for Alignment-Free Comparative and Predictive Studies. Recognition of Protease Inhibition Pattern from H-Depleted Molecular Graph Representation of Protease Sequences, Current Bioinformatics 2010; 5 (4) . https://dx.doi.org/10.2174/157489310794072490
DOI https://dx.doi.org/10.2174/157489310794072490 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Deep Learning in the Quest for Compound Nomination for Fighting COVID-19
Current Medicinal Chemistry Coronavirus (COVID-19) and Employee Health
Coronaviruses The Role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases
Current Pharmaceutical Design Vaccine Development Against SARS-CoV-2: From Virology to Vaccine Clinical Trials
Coronaviruses Is COVID-19 a Systemic Disease?
Coronaviruses Applying Knowledge of Enzyme Biochemistry to the Prediction of Functional Sites for Aiding Drug Discovery
Current Topics in Medicinal Chemistry A Comparison of CT Manifestations Between Coronavirus Disease 2019 (COVID-19) and Other Types of Viral Pneumonia
Current Medical Imaging Expression of a Tagless Single-Chain Variable Fragment (scFv) of Anti-TNF-α by a Salt Inducible System and its Purification and Characterization
Protein & Peptide Letters Pathogenesis of COVID-19, Disease Outbreak: A Review
Current Pharmaceutical Biotechnology Direct Targets and Subsequent Pathways for Molecular Hydrogen to Exert Multiple Functions: Focusing on Interventions in Radical Reactions
Current Pharmaceutical Design Renal Involvement in Pediatric Patients with COVID-19: An Up-to-date Review
Current Pediatric Reviews 1+1 > 2: Integration of the Host-directed Traditional Chinese Medicine and the Virus-targeted Modern Medicine in Control of COVID-19
Clinical Cancer Drugs Reinventing Electronic Health Records During COVID-19: Better Patient Data and Faster Research by Restructuring Electronic Health Record Systems
Current Women`s Health Reviews Targeting COVID-19 in Parkinson’s Patients: Drugs Repurposed
Current Medicinal Chemistry Engineering Novel Anticoagulant Proteins by Motif Grafting
Protein & Peptide Letters Could Targeting HMGB1 be Useful for the Clinical Management of COVID-19 Infection?
Combinatorial Chemistry & High Throughput Screening Interaction Between DNA/histone Methyltransferases and their Inhibitors
Current Medicinal Chemistry Impact of Headache Frequency and Sleep on Migraine Patients During the COVID-19 Pandemic
Current Neurovascular Research Discovery of Potential Inhibitors of SARS-CoV-2 (COVID-19) Main Protease (M<sup>pro</sup>) from <i>Nigella Sativa</i> (Black Seed) by Molecular Docking Study
Coronaviruses A Mechanistic Review on Plant-derived Natural Inhibitors of Human Coronaviruses with Emphasis on SARS-COV-1 and SARS-COV-2
Current Drug Targets